Status:
TERMINATED
Creatine as a New Therapeutic Strategy in Depression
Lead Sponsor:
Herzog Hospital
Collaborating Sponsors:
Beersheva Mental Health Center
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-75 years
Phase:
PHASE4
Brief Summary
Creatine as a new therapeutic strategy in depression: A double-blind, parallel, randomized, add-on clinical trial of creatine versus placebo added to antidepressant treatment of patients with major d...
Detailed Description
Dr.Boris Nemetz and Prof.Joseph Levine M.D., Beer Sheva Mental Health Center,Israel. Creatine plays a pivotal role in brain energy homeostasis, being a temporal and spatial buffer for cytosolic and m...
Eligibility Criteria
Inclusion
- Age:18-75 -
Exclusion
- \-
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00313417
Start Date
January 1 2007
End Date
December 1 2010
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beer Sheva Mental Health Center
Beersheba, Israel